Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Chubb
Queensland Health
Baxter
McKesson
Accenture
Cerilliant
Cipla

Generated: April 26, 2018

DrugPatentWatch Database Preview

DECLOMYCIN Drug Profile

« Back to Dashboard

When do Declomycin patents expire, and what generic alternatives are available?

Declomycin is a drug marketed by Lederle and Corepharma and is included in three NDAs.

The generic ingredient in DECLOMYCIN is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.
Drug patent expirations by year for DECLOMYCIN
Medical Subject Heading (MeSH) Categories for DECLOMYCIN
Synonyms for DECLOMYCIN
(2E,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride
(2Z,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride
(4S,4AS,5AS,6S,12AR)-7-CHLORO-4-(DIMETHYLAMINO)-1,6,10,11,12A-PENTAHYDROXY-3,12-DIOXO-3,4,4A,5,5A,6,12,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE HYDROCHLORIDE
(4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
(4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
[4S-(4|A,4a|A,5a|A,6|A,12a|A)]-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
[4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride
064D733
127-33-3 (Parent)
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride, (4S,4aS,5aS,6S,12aS)-
29O079NTYT
6-Demethyl-7-chlorotetracycline hydrochloride
64-73-3
7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
7-Chloro-6-demethyltetracycline hydrochloride
AC1NQXVY
AC1O7EUI
AK110703
AKOS015965080
BC219571
C-22948
C21H21ClN2O8.HCl
CAS-64-73-3
CC-26332
CCG-212562
CHEBI:59725
CHEMBL1200474
Clortetrin
CS-3073
D 6140
D00290
Declomycin (TN)
Declomycin hydrochloride
demeclocycline
Demeclocycline (hydrochloride)
Demeclocycline for system suitability, EuropePharmacopoeia (EP) Reference Standard
Demeclocycline HCL
Demeclocycline HCl, pharmaceutical secondary standard, traceable to USP, PhEur, BP
DEMECLOCYCLINE HYDROCHLORIDE
Demeclocycline hydrochloride (internal use)
Demeclocycline hydrochloride (USP)
Demeclocycline hydrochloride [USAN:BAN]
Demeclocycline hydrochloride [USP:BAN]
Demeclocycline hydrochloride, >=90% (HPLC), powder
Demeclocycline hydrochloride, Antibiotic for Culture Media Use Only
Demeclocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Demeclocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Demeplus
Demethylchlorotetracycline hydrochloride
Demethylchlortetracycline HCl
Demethylchlortetracycline HCl;
Demethylchlortetracycline hydrochloride
Demethylchlortetracycline hydrochloride (JP17)
Demetraciclina
Detracin
Detravis
DSSTox_CID_25252
DSSTox_GSID_45252
DSSTox_RID_80775
DTXSID0045252
EBD31499
EC 200-592-2
EINECS 200-592-2
Elkamicina
EU-0100421
FT-0603113
HMS1570G08
HMS1920C20
HY-17560
KS-00000Q36
Ledermicina
Ledermycin
Ledermycin hydrochloride
Ledermycine
LP00421
LS-93856
Meciclin
MFCD00082371
MLS000028422
MLS001076091
MLS001333687
MolPort-003-666-156
NCGC00016290-01
NCGC00162149-07
NCGC00261106-01
NSC-756708
NSC756708
Opera_ID_242
Pharmakon1600-01500226
PL009946
Prestwick_235
REGID_for_CID_54686764
s4279
SCHEMBL41286
SMR000058439
SPECTRUM1500226
SR-01000075825
SR-01000075825-1
ST24046427
Tox21_110354
Tox21_110354_1
Tox21_500421
UNII-29O079NTYT
Veraciclina
W-109265

US Patents and Regulatory Information for DECLOMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle DECLOMYCIN demeclocycline hydrochloride CAPSULE;ORAL 050262-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lederle DECLOMYCIN demeclocycline hydrochloride SYRUP;ORAL 050257-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Accenture
Covington
Baxter
McKesson
Julphar
US Department of Justice
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.